相似文献
1
[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer].
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):598-605. doi: 10.3779/j.issn.1009-3419.2011.07.07.
2
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
BMC Cancer. 2017 Nov 28;17(1):797. doi: 10.1186/s12885-017-3814-3.
3
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
J Clin Oncol. 2005 May 1;23(13):3125-37. doi: 10.1200/JCO.2005.00.224.
4
Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
Onkologie. 2004 Dec;27(6):583-8. doi: 10.1159/000081344.
5
Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced Non-Small Cell Lung Cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations - Still a daily challenge.
Eur J Cancer. 2017 Sep;83:266-278. doi: 10.1016/j.ejca.2017.07.002. Epub 2017 Jul 29.
6
Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece.
J Geriatr Oncol. 2015 Mar;6(2):111-8. doi: 10.1016/j.jgo.2014.11.001. Epub 2014 Dec 4.
7
Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
J Geriatr Oncol. 2013 Jul;4(3):282-90. doi: 10.1016/j.jgo.2013.04.005. Epub 2013 May 7.
8
Management of the elderly patient with advanced non-small cell lung cancer.
Int J Clin Pract. 2006 Mar;60(3):340-3. doi: 10.1111/j.1368-5031.2005.00795.x.
9
Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer.
Lung Cancer. 2003 Mar;39(3):233-53. doi: 10.1016/s0169-5002(02)00454-3.
10
Chemotherapy of advanced non small cell lung cancer in the elderly: an update.
Crit Rev Oncol Hematol. 2000 Sep;35(3):219-25. doi: 10.1016/s1040-8428(99)00064-5.
本文引用的文献
1
Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).
J Thorac Oncol. 2010 Dec;5(12):1970-6. doi: 10.1097/JTO.0b013e3181f49c22.
2
[The retrospective analysis of different therapies on 150 elderly patients with advanced non-small cell lung cancer.].
Zhongguo Fei Ai Za Zhi. 2009 Feb 20;12(2):122-6. doi: 10.3779/j.issn.1009-3419.2009.02.05.
3
Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more.
Lung Cancer. 2011 Feb;71(2):173-7. doi: 10.1016/j.lungcan.2010.05.014. Epub 2010 Jun 8.
4
[Management and outcome of French elderly patients with lung cancer: an IFCT survey].
Rev Mal Respir. 2010 May;27(5):421-30. doi: 10.1016/j.rmr.2010.02.013. Epub 2010 Mar 25.
5
[Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer].
Zhonghua Yi Xue Za Zhi. 2010 Jan 12;90(2):100-2.
6
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer.
J Clin Oncol. 2010 May 1;28(13):2191-7. doi: 10.1200/JCO.2009.25.4052. Epub 2010 Mar 29.
7
Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.
J Chemother. 2009 Nov;21(5):573-83. doi: 10.1179/joc.2009.21.5.573.
8
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.
Ann Oncol. 2010 Jun;21(6):1290-1295. doi: 10.1093/annonc/mdp525. Epub 2009 Nov 13.
9
Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer.
J Thorac Oncol. 2010 Jan;5(1):90-8. doi: 10.1097/JTO.0b013e3181c0a128.
10
Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer.
Ann Oncol. 2010 Apr;21(4):795-799. doi: 10.1093/annonc/mdp401. Epub 2009 Oct 8.
Zotero 插件